GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perrigo Co PLC (LTS:0Y5E) » Definitions » Short-Term Debt

Perrigo Co (LTS:0Y5E) Short-Term Debt : $441 Mil (As of Jun. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Perrigo Co Short-Term Debt?

Perrigo Co's Short-Term Debt for the quarter that ended in Jun. 2024 was $441 Mil.

Perrigo Co's quarterly Short-Term Debt stayed the same from Dec. 2023 ($441 Mil) to Mar. 2024 ($441 Mil) but then increased from Mar. 2024 ($441 Mil) to Jun. 2024 ($441 Mil).

Perrigo Co's annual Short-Term Debt declined from Dec. 2021 ($604 Mil) to Dec. 2022 ($36 Mil) but then increased from Dec. 2022 ($36 Mil) to Dec. 2023 ($441 Mil).


Perrigo Co Short-Term Debt Historical Data

The historical data trend for Perrigo Co's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perrigo Co Short-Term Debt Chart

Perrigo Co Annual Data
Trend Jun14 Jun15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.40 37.30 603.80 36.20 440.60

Perrigo Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.40 38.10 440.60 440.60 440.80

Perrigo Co Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Perrigo Co Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Perrigo Co's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Perrigo Co Business Description

Traded in Other Exchanges
Address
The Sharp Building, Hogan Place, Dublin, IRL, D02 TY74
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.

Perrigo Co Headlines

No Headlines